Back to the main directory
Press Release
- Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook by BusinessWire
- Lower Colorado River Authority Widens Wireless Communications Capabilities with Additional Spectrum Licenses from Anterix by GlobeNewsWire
- Arbutus Provides 2025 Corporate and Financial Update by GlobeNewsWire
- Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2024 Update by GlobeNewsWire
- Cytokinetics Announces 2025 Corporate Milestones and Vision 2030 by GlobeNewsWire
- Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance by GlobeNewsWire
- Mandalay Resources Delivers Strong Q4 Gold and Antimony Performance, Achieves Top End of 2024 Production Guidance Leading to $76 Million Cash Balance by GlobeNewsWire
- X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand by GlobeNewsWire
- Lifeward Cancels Its Extraordinary General Meeting of Shareholders by GlobeNewsWire
- Celestica Q4 2024 Financial Results and Conference Call Thursday, January 30, 2025 by GlobeNewsWire
- DTE Energy spends $3.3 billion with Michigan suppliers in 2024 by GlobeNewsWire
- Déclaration hebdomadaire des transactions sur CCI 06/01/2025 au 10/01/2025 by GlobeNewsWire
- VEON to List Kyivstar on Nasdaq in New York, Signs Letter of Intent with Cohen Circle by GlobeNewsWire
- CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia by GlobeNewsWire
- Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025 by GlobeNewsWire
- ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations by GlobeNewsWire
- NV5 Enters Agreement to Acquire Group Delta; Strengthens Southern California Infrastructure Engineering, Testing, and Environmental Services by GlobeNewsWire
- Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy by GlobeNewsWire
- Kratos Receives New Hypersonic System Program Award with Total Potential Value of Approximately $100 Million by GlobeNewsWire
- Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders by GlobeNewsWire
- TTM Technologies Honors Community Service with the 2024 TTM Chair of Community Service Award by GlobeNewsWire
- WSP dévoilera son plan d’action stratégique mondial 2025-2027 et tiendra une journée des investisseurs by GlobeNewsWire
- Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025 by GlobeNewsWire
- Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025 by GlobeNewsWire